BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12520325)

  • 1. Why is the oncogene WT1 in the developing kidney and what is it doing there?
    Chesney RW
    Pediatr Nephrol; 2002 Dec; 17(12):990-2. PubMed ID: 12520325
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial Wilms' tumor associated with a WT1 zinc finger mutation.
    Kaplinsky C; Ghahremani M; Frishberg Y; Rechavi G; Pelletier J
    Genomics; 1996 Dec; 38(3):451-3. PubMed ID: 8975729
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
    Machin GA
    Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
    [No Abstract]   [Full Text] [Related]  

  • 4. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
    Bardeesy N; Zabel B; Schmitt K; Pelletier J
    Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
    [No Abstract]   [Full Text] [Related]  

  • 5. The molecular genetics of Wilms tumor.
    Coppes MJ; Williams BR
    Cancer Invest; 1994; 12(1):57-65. PubMed ID: 8281465
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of the clinical and molecular genetics of Wilms' tumor.
    Grundy P; Coppes M
    Med Pediatr Oncol; 1996 Nov; 27(5):394-7. PubMed ID: 8827064
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic events in the development of Wilms' tumor.
    Coppes MJ; Haber DA; Grundy PE
    N Engl J Med; 1994 Sep; 331(9):586-90. PubMed ID: 8047084
    [No Abstract]   [Full Text] [Related]  

  • 8. WT1, a Wilms' tumour gene.
    Bard JB; Armstrong JF; Bickmore WA
    Exp Nephrol; 1993; 1(4):218-23. PubMed ID: 8081971
    [No Abstract]   [Full Text] [Related]  

  • 9. [WT1 (Wilms Tumor 1). Tumor suppressor gene].
    Bull Cancer; 1998 Dec; 85(12):983-4. PubMed ID: 9988551
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic stratification of Wilms tumor: is WT1 gene analysis ready for prime time?
    Geller JI
    Cancer; 2008 Sep; 113(5):893-6. PubMed ID: 18618514
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
    Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
    Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
    [No Abstract]   [Full Text] [Related]  

  • 14. WT1 nephropathy in a girl with normal karyotype (46,XX).
    Tsuda M; Owada M; Tsuchiya M; Murakami M; Sakiyama T
    Clin Nephrol; 1999 Jan; 51(1):62-3. PubMed ID: 9988151
    [No Abstract]   [Full Text] [Related]  

  • 15. Cloning of candidate genes involved in the Beckwith-Wiedemann syndrome and childhood tumors.
    Alders M; Bliek J; Redeker B; Ryan A; Feinberg A; Westerveld A; Little P; Mannens M
    Med Pediatr Oncol; 1996 Nov; 27(5):495-7. PubMed ID: 8827080
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular advances in pediatric urology.
    Pressler LB; Burbige KA; Connor JP
    Urology; 1995 Dec; 46(6):888-98. PubMed ID: 7502439
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
    Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
    Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental origin of WT1 mutations and mental retardation in WAGR syndrome.
    Huff V
    Nat Genet; 1994 Sep; 8(1):13-4. PubMed ID: 7987386
    [No Abstract]   [Full Text] [Related]  

  • 20. Paternally inherited WT1 mutation plus uniparental disomy of 11p may be an essential mechanism for development of WT1-mutated familial Wilms tumor.
    Sato Y; Haruta M; Kaneko Y; Nakasato Y; Kurosawa H; Yoshihara S
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27442. PubMed ID: 30221469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.